Mancuso, K.; Talarico, M.; Manzato, E.; Barbato, S.; Tacchetti, P.; Zamagni, E.; Cavo, M.
T-Cell Redirecting Therapies in Multiple Myeloma: Pathogenesis and Management of Toxicities Beyond CRS and ICANS. Cancers 2025, 17, 1514.
https://doi.org/10.3390/cancers17091514
AMA Style
Mancuso K, Talarico M, Manzato E, Barbato S, Tacchetti P, Zamagni E, Cavo M.
T-Cell Redirecting Therapies in Multiple Myeloma: Pathogenesis and Management of Toxicities Beyond CRS and ICANS. Cancers. 2025; 17(9):1514.
https://doi.org/10.3390/cancers17091514
Chicago/Turabian Style
Mancuso, Katia, Marco Talarico, Enrica Manzato, Simona Barbato, Paola Tacchetti, Elena Zamagni, and Michele Cavo.
2025. "T-Cell Redirecting Therapies in Multiple Myeloma: Pathogenesis and Management of Toxicities Beyond CRS and ICANS" Cancers 17, no. 9: 1514.
https://doi.org/10.3390/cancers17091514
APA Style
Mancuso, K., Talarico, M., Manzato, E., Barbato, S., Tacchetti, P., Zamagni, E., & Cavo, M.
(2025). T-Cell Redirecting Therapies in Multiple Myeloma: Pathogenesis and Management of Toxicities Beyond CRS and ICANS. Cancers, 17(9), 1514.
https://doi.org/10.3390/cancers17091514
